166 guidance documents the FDA is actively working on in 2024 (and beyond)

BY CHELSEY MCINTYRE, PHARMD, ALEXANDER GAFFNEY, MS, RAC

The FDA is set to be very, very busy in 2024. AgencyIQ has analyzed the agency’s guidance agendas, user fee commitment letters, statutory obligations and international efforts to determine which guidance documents the agency is actively working on this year (and in some cases, in the years ahead as well). We’ve identified a total of 166 guidance documents that are under active development, and have the key details for you.

Fill out the form to read the full article.

Required *

Copy link
Powered by Social Snap